Safety and efficacy of intra-procedural landiolol, a very short acting beta-1 adrenergic receptor blocker, in primary percutaneous coronary intervention for acute myocardial infarctio
Not Applicable
- Conditions
- Acute myocardial infarction
- Registration Number
- JPRN-UMIN000021668
- Lead Sponsor
- Yokohama City University Graduate School of Medicine Cardiorenal science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
HR<50bpm Killip>2 History of myocardial infarction 2or3 AV block B blocker before admission History of asthma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method